Fortrea Holdings, Inc. (FTRE)
10.53
-0.19
(-1.77%)
USD |
NASDAQ |
Mar 02, 11:28
Fortrea Holdings EPS Diluted (Quarterly) : -0.3502 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cytokinetics, Inc. | -1.495 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| IQVIA Holdings, Inc. | 2.990 |
| Medpace Holdings, Inc. | 4.666 |
| Charles River Laboratories International, Inc. | -5.619 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.50M |
| Revenue (Quarterly) | 660.50M |
| Total Expenses (Quarterly) | 693.00M |
| Enterprise Value | 1.932B |
| Gross Profit Margin (Quarterly) | 16.93% |
| Profit Margin (Quarterly) | -4.92% |
| Earnings Yield | -103.6% |
| Normalized Earnings Yield | -41.74 |